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Hepatitis C virus (HCV) interacts extensively with host factors to not
only establish productive infection but also trigger unique patholog-
ical processes. Our recent genome-wide siRNA screen demonstrated
that IjB kinase-a (IKK-a) is a crucial host factor for HCV. Here we
describe a new nuclear factor jB (NF-jB)-independent and kinase-
mediated nuclear function of IKK-a in HCV assembly. HCV, through
its 30 untranslated region, interacts with DEAD box polypeptide 3,
X-linked (DDX3X) to activate IKK-a, which translocates to the
nucleus and induces a CBP/p300-mediated transcriptional program
involving sterol regulatory element-binding proteins (SREBPs). This
innate pathway induces lipogenic genes and enhances core-associ-
ated lipid droplet formation to facilitate viral assembly. Chemical
inhibitors of IKK-a suppress HCV infection and IKK-a-induced lipo-
genesis, offering a proof-of-concept approach for new HCV therapeu-
tic development. Our results show that HCV uses a novel mechanism
to exploit intrinsic innate responses and hijack lipid metabolism,
which may contribute to high chronicity rates and the pathological
hallmark of steatosis in HCV infection. 2013 European Association for the Study of the Liver. Published
by Elsevier B.V.
One of the pathological hallmarks of hepatitis C virus (HCV)
infection includes the accumulation of cytosolic lipid droplets
resulting in steatosis. Upon infection, HCV utilizes lipid droplets
as platforms for viral assembly [1]. Another feature of HCV is
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gen-associated molecular patterns (PAMPs) activate inﬂamma-
tory responses including the induction of interferons. Qisheng
Li and colleagues from Jake Liang’s laboratory at the Liver
Diseases Branch, NIDDK, National Institutes of Health, Bethesda
have revealed a new connection between innate response and
lipid accumulation, unexpectedly involving a protein in the
nuclear factor jB (NF-jB) pathway [3]. Through a previous
two-step siRNA screen that distinguished HCV entry and replica-
tion from production, the authors identiﬁed IjB kinase-a (IKK-a)
as being critical in HCV infection [4]. Genetic knockdown of IKK-a
dramatically inhibited HCV propagation primarily at the level of
HCV assembly, while IKK-a overexpression boosted the quantity
of HCV produced. Through using multiple strategies, the authors
conﬁrmed that IKK-a is speciﬁcally critical for HCV assembly.
The canonical NF-jB pathway involves retention of NF-jB in
the cytosol in complex with inhibitors of NF-jB (IjB) [5]. Phos-
phorylation of IjB by the IjB kinase (IKK) complex target IjB
for degradation, releasing NF-jB to translocate to the nucleus
and transcriptionally activate target genes (Fig. 1). The canonical
pathway is driven by the kinase activity of IKK-b, whereas NEMO
has a regulatory function, and IKK-a predominantly functions in
an alternate, non-canonical pathway [5]. However, recent evi-
dence suggests that IKK-a additionally has NF-jB independent
functions, which are an ongoing intense area of research.
HCV assembly and production rely on lipid droplets and HCV
infection results in an increased quantity of these organelles. Li
et al. showed that knockdown of IKK-a reversed this increase in
lipid storage, whereas overexpression boosted lipid droplet count
over and above HCV infection alone, indicative of IKK-a being a
critical mediator of HCV-induced lipid accumulation [3]. Knowing
that there are PAMPs present in the 30 untranslated region (UTR)
of the HCV genome, the authors found that this region activates
lipid droplet formation through phosphorylation and activation
of IKK-a. Surprisingly, this role of IKK-a is not affected when
the other elements of the NF-jB pathway are either silenced or
activated; IKK-a mediates HCV lipid droplet induction indepen-
dently of other NF-jB pathway components. To deﬁne the con-
nection between the HCV 30UTR, IKK-a, and lipid droplet
induction, the authors looked to a recently identiﬁed PAMP rec-
ognition receptor (PRR) important in innate responses and HCV
infection, DDX3X. Interestingly, the presence of the HCV 30UTR
induced a complex formation including the 30UTR, DDX3X, and
IKK-a. The formation of this complex results in the phosphoryla-
tion, nuclear translocation, and activation of IKK-a [3].13 vol. 59 j 1118–1120
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Fig. 1. HCV co-opts IKK-a to promote HCV assembly. The canonical nuclear factor (NF)-jB pathway involves an NF-jB family member bound to an inhibitor of NF-jB
(IjB) that retains the complex in the cytoplasm. Upon IjB phosphorylation from the IjB kinase (IKK) complex, IjB is degraded, liberating NF-jB to translocate to the
nucleus and to regulate genes involved in innate immunity [5]. The IKK complex consists of NF-jB essential modiﬁer (NEMO), and IKK catalytic units IKK-a and IKK-b. The
30 untranslated region (UTR) contains a pathogen-associated molecular pattern (PAMP) that forms a complex with DDX3X, activating IKK-a. Active IKK-a and CREB binding
protein (CBP/p300) subsequently bind the promoter and transcriptionally activate sterol response element binding protein 1 (SREBP-1). SREBP-1 transcriptionally drives
lipogenic genes resulting in an accumulation of lipid droplets [6]. HCV uses lipid droplets as platforms for assembly [1], and all of the factors involved in this IKK-amediated
pathway are important for the HCV life cycle [3].
JOURNAL OF HEPATOLOGYThe above discoveries already represent a substantial advance
in HCV biology, but the remaining piece of the puzzle is how all of
this mechanism results in lipid droplet accumulation. The inves-
tigators examined IKK-a transcriptional targets by coupling siR-
NA of IKK-a with microarray and found a dramatic
downregulation of sterol response element binding proteins
(SREBPs) and their target genes. SREBPs are transcription factors
that are master regulators of lipid synthesis [6]. HCV infection
increased SREBP mRNA levels, a transcriptional activation that
could be reversed by knockdown of IKK-a. The authors then
revealed that SREBP-1 transcriptional activation was not only
facilitated by IKK-a binding the SREBP-1 promoter, but also
through IKK-a activation of another critical transcription factor,
CREB binding protein (CBP/p300) [7].Journal of Hepatology 2013This study represents an astounding advance of understand-
ing HCV infection, innate responses, and lipid metabolism. The
cellular response of HCV PAMP recognition ultimately results in
induction of lipogenesis, in turn stimulating HCV viral produc-
tion. Co-opting factors of innate immunity for viral propagation
is a dramatic adaptation that likely facilitates HCV being so effec-
tive in establishing chronic infection. Aside from providing a pos-
sible mechanism for the clinical observations of HCV induced
steatosis, the study reveals a full and complex pathway, rich in
possible therapeutic targets. As an increasing population is taking
lipid-modulating drugs including statins, these results may
inform unwanted side-effects of these therapies in HCV-infected
individuals. Indeed, statins increase SREBP-1 transcription [8], yet
evidence indicates that statins act synergistically with pegylatedvol. 59 j 1118–1120 1119
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interferon and ribavirin to inhibit infection [9]. The complex
interaction of HCV with lipids will continue to be an important
consideration as the next generation of direct acting antiviral
agents are tested and utilized. Although the screen did not reveal
IKK-a as critical for HIV-1, Dengue, West Nile, or inﬂuenza infec-
tion [3], the role of the DDX3X-IKK-a complex will be assertively
investigated for its role in other pathogenic and inﬂammatory
diseases. Interestingly, a single nucleotide polymorphism associ-
ated with non-alcoholic fatty liver disease has been located in the
gene encoding IKK-a [10]. The recent investigation by Li et al.
promises to act as a springboard to a new paradigm of liver dis-
ease, lipid metabolism, and inﬂammation.Financial support
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